GO
Loading...

Eli Lilly's Zyprexa Issues

Monday, 18 Dec 2006 | 9:10 AM ET

Eli Lilly may have downplayed the risk of its top-selling schizophrenia drug - Zyprexa. Mike Huckman, CNBC Pharmaceuticals Reporter, and Erin Burnett discuss the details.